BioScience Health Innovations annual revenue
2020
2021
2022
2022
2023
2024
2025
BioScience Health Innovations Revenue Growth & History (BHIC)
BioScience Health Innovations reported $5.7M in revenue for fiscal 2025, an increase of 208.34% from the previous fiscal year.
View full BioScience Health Innovations company overviewBioScience Health Innovations annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $5.7M | $3.8M | +208.34% |
| 2024 | 2024-12-31 | $1.8M | $1.2M | +208.73% |
| 2023 | 2023-12-31 | $597,595 | $528,252 | +761.80% |
| 2022 · Dec 31 | 2022-12-31 | $69,343 | — | — |
| 2022 · Aug 31 | 2022-08-31 | $0 | $0 | — |
| 2021 | 2021-08-31 | $0 | $0 | — |
| 2020 | 2020-08-31 | $0 | — | — |
BioScience Health Innovations quarterly revenue
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q2.22
Q3.22
Q3.22
Q3.22
Q1.23
Q1.23
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.0M | −$721,099 | −41.03% |
| Q1 2026 | 2026-03-31 | $750,946 | −$476,124 | −38.80% |
| Q4 2025 | 2025-12-31 | $1.6M | $962,535 | +157.74% |
| Q3 2025 | 2025-09-30 | $1.1M | $558,454 | +97.47% |
| Q2 2025 | 2025-06-30 | $1.8M | $1.4M | +357.47% |
| Q1 2025 | 2025-03-31 | $1.2M | $949,469 | +342.03% |
| Q4 2024 | 2024-12-31 | $610,222 | $306,594 | +100.98% |
| Q3 2024 | 2024-09-30 | $572,973 | $380,808 | +198.17% |
| Q2 2024 | 2024-06-30 | $384,170 | $314,705 | +453.04% |
| Q1 2024 | 2024-03-31 | $277,601 | $245,264 | +758.46% |
| Q4 2023 | 2023-12-31 | $303,628 | — | — |
| Q3 2023 | 2023-09-30 | $192,165 | $172,438 | +874.12% |
| Q2 2023 | 2023-06-30 | $69,465 | $61,416 | +763.03% |
| Q1 2023 · Mar 31 | 2023-03-31 | $32,337 | $32,058 | +11490.32% |
| Q1 2023 · Feb 28 | 2023-02-28 | $0 | $0 | — |
| Q1 2023 · Nov 30 | 2022-11-30 | $0 | $0 | — |
| Q3 2022 · Sep 30 | 2022-09-30 | $19,727 | — | — |
| Q3 2022 · Jun 30 | 2022-06-30 | $8,049 | — | — |
| Q3 2022 · May 31 | 2022-05-31 | $0 | $0 | — |
| Q2 2022 · Mar 31 | 2022-03-31 | $279 | — | — |
| Q2 2022 · Feb 28 | 2022-02-28 | $0 | $0 | — |
| Q1 2022 | 2021-11-30 | $0 | $0 | — |
| Q4 2021 | 2021-08-31 | $0 | $0 | — |
| Q3 2021 | 2021-05-31 | $0 | $0 | — |
| Q2 2021 | 2021-02-28 | $0 | $0 | — |
| Q1 2021 | 2020-11-30 | $0 | $0 | — |
| Q4 2020 | 2020-08-31 | $0 | — | — |
| Q3 2020 | 2020-05-31 | $0 | — | — |
| Q2 2020 | 2020-02-29 | $0 | — | — |
| Q1 2020 | 2019-11-30 | $0 | — | — |
BioScience Health Innovations revenue growth trends
BioScience Health Innovations's latest reported quarter, Q2 2026, generated $1.0M in revenue, a decrease of 41.03% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review BioScience Health Innovations source filings ↗